Comparison of Standard of Care or Treatment on Protocol
Randomized Study of Patients (Patient Choice) Who Are Not Eligible for Variations of Standard of Care Protocols When Treated Either on Best Standard of Care Pathways or Per a Protocol Arm That They Failed to Enroll to
Sponsor: New Mexico Cancer Research Alliance
Terminated
PI deparature and very low (\<2%) accrual rate.(No results required)
Other terminated trials from New Mexico Cancer Research Alliance
- Leukemia, Acute Lymphoblastic · Phase NA · Oct 2022
- Bile Duct Cancer · Phase PHASE2 · Mar 2017
- Cancer · Phase NA · Dec 2015
- Recurrent Non-small Cell Lung Cancer · Phase PHASE1 · Oct 2015
- Multiple Myeloma in Relapse · Phase PHASE1 · Jul 2015
See all terminations from New Mexico Cancer Research Alliance
Other Bladder Cancer trials with similar outcome
This NA trial investigates Bladder Cancer and Esophageal Cancer and is currently terminated or withdrawn. New Mexico Cancer Research Alliance leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Jan 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Jan 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Mar 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- New Mexico Cancer Research Alliance
For direct contact, visit the study record on ClinicalTrials.gov .